267 related articles for article (PubMed ID: 24187399)
1. Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions.
Delvoux B; D'Hooghe T; Kyama C; Koskimies P; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2014 Jan; 99(1):276-84. PubMed ID: 24187399
[TBL] [Abstract][Full Text] [Related]
2. Estrogen metabolizing enzymes in endometrium and endometriosis.
Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
[TBL] [Abstract][Full Text] [Related]
3. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.
Zeitoun K; Takayama K; Sasano H; Suzuki T; Moghrabi N; Andersson S; Johns A; Meng L; Putman M; Carr B; Bulun SE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4474-80. PubMed ID: 9851796
[TBL] [Abstract][Full Text] [Related]
4. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism.
Delvoux B; Groothuis P; D'Hooghe T; Kyama C; Dunselman G; Romano A
J Clin Endocrinol Metab; 2009 Mar; 94(3):876-83. PubMed ID: 19088158
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis.
Smuc T; Pucelj MR; Sinkovec J; Husen B; Thole H; Lanisnik Rizner T
Gynecol Endocrinol; 2007 Feb; 23(2):105-11. PubMed ID: 17454161
[TBL] [Abstract][Full Text] [Related]
6. Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism.
Cheng YH; Imir A; Fenkci V; Yilmaz MB; Bulun SE
Am J Obstet Gynecol; 2007 Apr; 196(4):391.e1-7; discussion 391.e7-8. PubMed ID: 17403431
[TBL] [Abstract][Full Text] [Related]
7. Expression of 17beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis.
Carneiro MM; Morsch DM; Camargos AF; Spritzer PM; Reis FM
Gynecol Endocrinol; 2007 Apr; 23(4):188-92. PubMed ID: 17505937
[TBL] [Abstract][Full Text] [Related]
8. 17Beta-hydroxysteroid dehydrogenases in human endometrium and its disorders.
Ito K; Utsunomiya H; Suzuki T; Saitou S; Akahira J; Okamura K; Yaegashi N; Sasano H
Mol Cell Endocrinol; 2006 Mar; 248(1-2):136-40. PubMed ID: 16406263
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biological evaluation of novel potent coumarin inhibitor of 17β-HSD type 1.
Starčević S; Kocbek P; Hribar G; Rižner TL; Gobec S
Chem Biol Interact; 2011 May; 191(1-3):60-5. PubMed ID: 21232530
[TBL] [Abstract][Full Text] [Related]
10. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G
Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205
[TBL] [Abstract][Full Text] [Related]
11. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women.
Luu-The V; Tremblay P; Labrie F
Mol Endocrinol; 2006 Feb; 20(2):437-43. PubMed ID: 16166196
[TBL] [Abstract][Full Text] [Related]
12. 17beta-hydroxysteroid dehydrogenases in human breast cancer.
Nagasaki S; Miki Y; Akahira J; Suzuki T; Sasano H
Ann N Y Acad Sci; 2009 Feb; 1155():25-32. PubMed ID: 19250189
[TBL] [Abstract][Full Text] [Related]
13. [Study on inhibitory effect of medicated serum of SLW on estrogen production by human endometrial cells of endometriosis].
Li A; Xu XY; Wang H; Chen G
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):686-90. PubMed ID: 18590202
[TBL] [Abstract][Full Text] [Related]
14. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
15. Differential estrogenic 17beta-hydroxysteroid dehydrogenase activity and type 12 17beta-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes.
Bellemare V; Laberge P; Noël S; Tchernof A; Luu-The V
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):129-34. PubMed ID: 19429442
[TBL] [Abstract][Full Text] [Related]
16. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
17. Progesterone resistance in endometriosis: link to failure to metabolize estradiol.
Bulun SE; Cheng YH; Yin P; Imir G; Utsunomiya H; Attar E; Innes J; Julie Kim J
Mol Cell Endocrinol; 2006 Mar; 248(1-2):94-103. PubMed ID: 16406281
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of 17 beta-hydroxysteroid dehydrogenases.
Poirier D
Curr Med Chem; 2003 Mar; 10(6):453-77. PubMed ID: 12570693
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol.
Tremblay MR; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2005 Apr; 20(2):153-63. PubMed ID: 15968820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]